Mawson Infrastructure Group Inc. — Director's Dealing 2019

Sep 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2019-06-30

Reporting Person: Danenberg Noam (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-30	Common Stock	M	17500	—	Acquired	142500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-30	Restricted Stock Units (RSU)	$	M	17500	Disposed		Common Stock (17500)	Direct

Footnotes

F1: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock.

F2: On March 31, 2019, the reporting person was granted 140,000 restricted stock units, vesting quarterly over a two-year period with the first installment issued on June 30, 2019.